Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

BlackRock, Inc. reported a 6.40% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed Apr 27, 2026

BlackRock, Inc. reported a 6.40% stake in Corvus Pharmaceuticals, Inc., 5,387,818 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G/A).

Stake
6.40%
Shares
5,387,818
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.6.40%5,387,818

Source

View original at SEC

Related